To the best of our knowledge, this study is the first to establish that EZH2 is a pro-angiogenic mediator in NPC tumorigenesis and delineate an oncogenic pathway that functionally links EZH2 with ET-1 via miR-1. This evidence concerns the gene EDN1 and nasopharyngeal carcinoma.